Whole‐exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late

Developmental and epileptic encephalopathies (DEE) encompass rare, sporadic neurodevelopmental disorders and usually with pediatric onset. As these conditions are characterized by marked clinical and genetic heterogeneity, whole‐exome sequencing (WES) represents the strategy of choice for the molecular diagnosis. While its usefulness is well established in pediatric DEE cohorts, our study is aimed at assessing the WES feasibility in adult DEE patients who experienced a diagnostic odyssey prior to the advent of this technique. We analyzed exomes from 71 unrelated adult DEE patients, consecutively recruited from an Italian cohort for the EPI25 Project. All patients underwent accurate clinical and electrophysiological characterization. An overwhelming percentage (90.1%) had already undergone negative genetic testing. Variants were classified according to the American College of Medical Genetics and Genomics guidelines. WES disclosed 24 (likely) pathogenic variants among 18 patients in epilepsy‐related genes with either autosomal dominant, recessive or X‐linked inheritance. Ten of these were novel. We obtained a diagnostic yield of 25.3%, higher among patients with brain malformations, early‐onset epilepsy and dysmorphisms. Despite a median diagnostic delay of 38.7 years, WES analysis provided the long‐awaited diagnosis for 18 adult patients, which also had an impact on the clinical management of 50% of them.

[1]  M. Alfadhel,et al.  Genomic testing and counseling: The contribution of next‐generation sequencing to epilepsy genetics , 2020, Annals of human genetics.

[2]  C. Steward,et al.  A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability , 2020, European Journal of Human Genetics.

[3]  A. Munnich,et al.  Primrose syndrome: a phenotypic comparison of patients with a ZBTB20 missense variant versus a 3q13.31 microdeletion including ZBTB20 , 2020, European Journal of Human Genetics.

[4]  A. Poduri,et al.  Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort , 2020, Epilepsia.

[5]  F. Santorelli,et al.  Customized multigene panels in epilepsy: the best things come in small packages , 2019, neurogenetics.

[6]  Kiely N. James,et al.  Bi-allelic Loss of Human APC2, Encoding Adenomatous Polyposis Coli Protein 2, Leads to Lissencephaly, Subcortical Heterotopia, and Global Developmental Delay. , 2019, American journal of human genetics.

[7]  Michael R. Johnson,et al.  Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals , 2019, bioRxiv.

[8]  R. Pfundt,et al.  Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability , 2018, Epilepsia.

[9]  Deciphering Developmental Disorders Study,et al.  De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias , 2018 .

[10]  Klaus Lehnert,et al.  De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. , 2018, American journal of human genetics.

[11]  D. Dyment,et al.  Epilepsy genetics: Current knowledge, applications, and future directions , 2018, Clinical genetics.

[12]  R. Mcfarland,et al.  Overview of Approaches to Mitochondrial Disease Therapy , 2018 .

[13]  Edouard Hirsch,et al.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.

[14]  R. Płoski,et al.  New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre , 2016, Journal of Translational Medicine.

[15]  J. Rivière,et al.  Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test , 2016, Clinical genetics.

[16]  J. Conroy,et al.  Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion , 2016, Epilepsia.

[17]  Z. Nawaz,et al.  Loss-of-Function Mutation in APC2 Causes Sotos Syndrome Features. , 2015, Cell reports.

[18]  I. Scheffer,et al.  Transition to adult life in the monogenic epilepsies , 2014, Epilepsia.

[19]  K. Veeramah,et al.  Exome sequencing reveals new causal mutations in children with epileptic encephalopathies , 2013, Epilepsia.

[20]  F. Garaci,et al.  Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  S. Sisodiya,et al.  Array comparative genomic hybridization: Results from an adult population with drug-resistant epilepsy and co-morbidities , 2012, European journal of medical genetics.